A federal court ruling has delivered a significant legal and political setback to Health and Human Services Secretary Robert F. Kennedy Jr.'s campaign to overhaul the nation's vaccine framework. U.S. District Judge Brian E. Murphy granted a preliminary injunction on Monday, halting Kennedy's reduced childhood immunization schedule and his appointment of more than a dozen new members to the Centers for Disease Control and Prevention's vaccine advisory panel.
The decision effectively invalidates all recommendations made by the reconstituted panel, cancels its future meetings, and rolls back the secretary's most consequential policy shifts from the past year. Legal experts described the ruling as a major intervention in public health governance. "From our perspective, this was one of the most consequential cases around public health in a very long time," said Alison Barkoff, director of the Hirsh Health Law and Policy Program at George Washington University.
Judge Murphy found that Kennedy's actions violated the Administrative Procedures Act by enacting the immunization schedule changes without proper input from the existing CDC advisory committee. The HHS had defended the new schedule by arguing it aligned the U.S. with peer nations like Denmark, but the court rejected that justification. "What the Administrative Procedures Act is really about... is that when government makes decisions, they have to explain why. They have to justify it and show their thinking. And that is exactly what did not happen here," Barkoff explained.
The legal defeat coincides with growing reports that the White House is losing patience with Kennedy's vaccine agenda. According to two officials who spoke to Stat, the administration is "just kind of done with the vaccine issue." This sentiment echoes broader tensions within the administration over policy independence. The Wall Street Journal similarly reported that White House officials are taking a more active role in HHS affairs amid frustration with the department's unpopular decisions.
Political observers note the relationship between President Trump and his HHS secretary appears increasingly transactional. "His primary and perhaps only belief is that he is the greatest, the best... he knows more than the generals, he knows more than the doctors—and people like Robert Kennedy have figured out that the easiest way to get what they want is to make Donald believe they can do something for him," said Mary Trump, the president's niece, at a recent political event. With midterm elections approaching, where Republican control of Congress is under threat, the president's association with controversial health policies may offer diminishing returns.
Public confidence metrics further complicate Kennedy's position. A poll from the Annenberg Public Policy Center found only 38% of respondents were confident in Kennedy providing public health information, with a mere 9% expressing strong confidence. This contrasts with 54% confidence in former White House medical adviser Anthony Fauci. When pressed for comment on the court ruling, the White House sidestepped the vaccine issue entirely, stating it remains focused on "food, nutrition, and other lifestyle issues that are driving America's chronic disease epidemic."
Some analysts caution that the court's decision was procedural, not a substantive rejection of Kennedy's policy goals. "The judge ruled, I think appropriately, that Secretary Kennedy did not follow the proper procedures relative to public health policy, not that that public health policy was wrong," said Peter Pitts, co-founder of the Center for Medicine in the Public Interest and a former FDA official. "I don't think that it is as complete a victory for sanity and public health that people think it is."
HHS spokesperson Andrew Nixon indicated the agency will appeal the ruling. Barkoff suggested the injunction would likely withstand scrutiny at the circuit court level, but noted a potential Supreme Court review would be harder to predict. Even if the ruling is upheld, Pitts argued that legally reconstituting the advisory panel may not fully counteract the influence of Kennedy's tenure, leaving a lasting imprint on the nation's public health infrastructure.
